Singular Genomics is latest early stage San Diego startup to seek an IPO

Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Founded in 2016, Singular hasn't disclosed yet how much money it hopes to raise or the proposed price range of its shares. That information should...